THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt as to what action you should take, you are recommended to seek your own financial advice. | June 6, 2023
Biotech Executive Brings Extensive Experience Developing Advanced Therapies and Regenerative MedicinesLEXINGTON, Mass. and AMSTERDAM, Oct. 21, 2021N.V. (NASDAQ: QURE), a leading gene therapy company advancing
Alliance for Regenerative Medicine Annual Report Highlights Record Sector Growth and Resilience in 2020
ALLIANCE FOR REGENERATIVE MEDICINE ANNUAL REPORT HIGHLIGHTS RECORD SECTOR GROWTH AND RESILIENCE IN 2020
Sector financing reached $19.9B in 2020, doubling from the previous year; 2021 is likely to be a record year for the number of regulatory decisions on new ATMPs
BRUSSELS, Belgium – March 16, 2020
The regenerative medicine and advanced therapies sector raised a record $19.9B in funding in 2020, fueling the broader biotech sector and driving a rapidly advancing pipeline of potentially transformative therapies, according to the Alliance for Regenerative Medicine’s (ARM)
Two new therapies received approval in 2020: Orchard Therapeutics’ gene therapy Libmeldy, by the European Medicines Agency (EMA), and Kite’s Tecartus chimeric antigen receptor T-cell (CAR-T) therapy, by the Food & Drug Administration (FDA). By the end of 2020, there were 152 ongoing Phase 3 trials world
The Alliance for Regenerative Medicine: Alliance for Regenerative Medicine Annual Report Highlights Record Sector Growth and Resilience in 2020 finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.